Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Veritas Collaborative was a U.S. specialty healthcare company focused on the treatment of eating disorders across a full continuum of care, including inpatient, residential, partial hospitalization, intensive outpatient, outpatient, and virtual services. Founded in Durham, North Carolina, the organization served children, adolescents, and adults and emphasized multidisciplinary, evidence-based, gender-inclusive care. Its clinical focus centered on eating disorders such as anorexia nervosa, bulimia nervosa, binge eating disorder, ARFID, and OSFED rather than drug development. Veritas merged with The Emily Program in 2021 under parent company Accanto Health, initially retaining its brand in the Southeast. In July 2024, the Veritas Collaborative brand was retired and rebranded under The Emily Program, so Veritas no longer operates as an active standalone company or brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Veritas Collaborative.